4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-26-013630
Director sold 22,000 shares at an average $9.51 ($209,181)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SATO VICKI L Director | 2026-03-02 | Sale 10b5-1 | −21,800 | $9.50 | $207,185 | 1,122,591 | D |
| SATO VICKI L Director | 2026-03-02 | Sale 10b5-1 | −200 | $9.98 | $1,996 | 1,122,391 | D |
| Open-market sales · 22,000 sh · avg $9.51 · $209,181 | |||||||
Loading xslF345X05/wk-form4_1772557800.xml…